Biovest International competitors

Zippia score 3.8

Competitor Summary. See how Biovest International compares to its main competitors:

Teva Pharmaceuticals has the most employees (4,999).

Work at Biovest International?

Share your experience

Biovest International vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Biovest International	1981	3.8	Minneapolis, MN	1	$8.0M	125
Accentia Biopharmaceuticals Inc	2002	3.9	Tampa, FL	1	$4.1M	50
Eureka Therapeutics	2006	3.8	Emeryville, CA	1	$500,000	50
Goodwin Bio	1992	4.1	Plantation, FL	1	$10.5M	50
Medefil	1998	4.4	Glendale Heights, IL	1	$20.6M	65
Nephros	1997	3.7	South Orange Village, NJ	1	$14.2M	18
Invagen Pharmaceuticals Inc.	-	3.8	Hauppauge, NY	2	$1.0M	50
Surmodics	1979	4.3	Eden Prairie, MN	1	$126.1M	369
Teva Pharmaceuticals	1901	4.8	North Wales, PA	9	$16.5B	4,999
Kabco	-	3.9	Amityville, NY	1	$950,000	2
FUJIFILM Diosynth Biotechnologies	2011	4.0	Morrisville, NC	2	$124.3M	3,000

Rate Biovest International's competitiveness in the market.

Biovest International salaries vs competitors

Compare Biovest International salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Biovest International	$65,893	$31.68	-

Compare Biovest International job title salaries vs competitors

Company	Highest salary	Hourly salary
Biovest International	$93,787	$45.09
FUJIFILM Diosynth Biotechnologies	$108,579	$52.20
Teva Pharmaceuticals	$97,878	$47.06
Kabco	$96,572	$46.43
Eureka Therapeutics	$95,747	$46.03
Surmodics	$94,564	$45.46
Accentia Biopharmaceuticals Inc	$94,242	$45.31
Nephros	$93,573	$44.99
Invagen Pharmaceuticals Inc.	$93,381	$44.89
Goodwin Bio	$93,360	$44.88
Medefil	$93,356	$44.88

Do you work at Biovest International?

Does Biovest International effectively differentiate itself from competitors?

Biovest International jobs

Biovest International demographics vs competitors

Compare gender at Biovest International vs competitors

Job title	Male	Female
Goodwin Bio	49%	51%
Surmodics	53%	47%
Teva Pharmaceuticals	59%	41%
Nephros	62%	38%
FUJIFILM Diosynth Biotechnologies	63%	38%
Biovest International	-	-

Male

Female

100%

75%

50%

25%

Biovest International

FUJIFILM Diosynth Biotechnologies

Nephros

Teva Pharmaceuticals

Surmodics

Goodwin Bio

25%

50%

75%

100%

Compare race at Biovest International vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Surmodics	61%	11%	10%	13%	6%	7.6
Teva Pharmaceuticals	60%	14%	10%	12%	4%	9.9
Nephros	67%	14%	10%	5%	4%	6.1
Goodwin Bio	50%	29%	11%	7%	4%	8.2
FUJIFILM Diosynth Biotechnologies	52%	14%	16%	13%	5%	7.7

Biovest International and similar companies CEOs

CEOBio

Gary R. Maharaj

Surmodics

Gary Maharaj is a Board Member at Faegre & Benson LLP, Board Member at NVE Corp, and President/CEO at SURMODICS INC. He has experience at Smith & Nephew and has worked as President/CEO at Arizant Inc and Vice President at Philip Adam & Assoc. Gary studied at Carlson School of Management, UT Southwestern Medical Center, and University of Texas System.

Andrew Astor

Nephros

Accomplished, entrepreneurial business and financial executive with over 30 years’ success directing business-driven change in a variety of industries, ranging from global organizations to startups. Known for assembling and motivating extraordinary teams, articulating future state visions, establishing financial and operational process excellence, and driving change with an effective balance of urgency and quality. Industry experience includes insurance and financial services, mobile and wireless, databases and software tools, and consulting. Passionate relationship builder. Developer of talent and trusted strategic partnerships. Specialties: Strategic planning; Financial leadership; Organizational growth and turnarounds; Talent strategy and development; Portfolio, program, and project leadership; Mergers and acquisitions; Technology strategy and leadership; Quality improvement; Global/offshore teams.

Karl Pinto

Goodwin Bio

Experienced Biopharma & Technology Founder, Executive & Board Member with a demonstrated history of working in the Life Sciences & Information Technology industries across continents.

Nikhil Lalwani

Invagen Pharmaceuticals Inc.

Martin Meeson

FUJIFILM Diosynth Biotechnologies

Martin Meeson is a President,Founder and Chief Executive Officer at FUJIFILM Diosynth and President and Chief Executive Officer at FUJIFILM Diosynth Biotechnologies and is based in Morrisville, North Carolina. He attended Newcastle University.